Planetary Closes $17.44M Series A Led by Radical Capital and Oetker Group

Why It Matters

By leveraging existing sugar‑industry infrastructure, Planetary reduces capital barriers and accelerates scale‑up, setting a template for capital‑efficient climate‑tech financing. The model demonstrates that strategic licensing and early retail traction can unlock sizable venture capital for alternative‑protein innovators.

Key Takeaways

• Planetary raised $17.4M Series A, co-led by Radical Capital and Oetker
• Licenses fermentation IP to sugar producers, avoiding own CapEx
• Aldi’s vegan chicken reorder validated market, de‑risking investors
• BioBlocks™ AI platform streamlines scale‑up across mycoprotein, precision fermentation
• Swiss startup positions itself as infrastructure‑as‑service for bioeconomy

Pulse Analysis

The alternative‑protein sector is entering a new funding era, with investors seeking scalable, low‑capex pathways to meet rising consumer demand. Planetary’s $17.4 million Series A illustrates how biotech firms can sidestep the traditional, expensive construction of fermentation plants by licensing their proprietary BioBlocks™ platform to legacy sugar manufacturers. This approach not only repurposes existing infrastructure but also taps into the abundant sucrose side‑streams, turning them into high‑protein mycoprotein ingredients for B2B customers.

A pivotal moment for Planetary came when retail giant Aldi placed a reorder for its vegan chicken fillet, providing concrete market validation that resonated with venture capitalists. The reorder acted as a de‑risking mechanism, assuring investors that the product could achieve commercial traction without extensive marketing spend. Coupled with a data‑room strategy likened to selling a house, the company generated strong FOMO among VCs, culminating in a co‑led Series A by Radical Capital and the Oetker Group.

Planetary’s model signals a broader shift toward infrastructure‑as‑a‑service in the bioeconomy. By offering a turnkey fermentation platform, the startup enables other food‑tech innovators to accelerate product development while keeping cost of goods low and sustainability metrics high. This licensing‑centric playbook could become a blueprint for climate‑tech firms aiming to attract sizable funding without the heavy capital outlay traditionally required for large‑scale biomanufacturing.

Deal Summary

Swiss biotech startup Planetary announced the close of a $17.44 million Series A round co‑led by Radical Capital and Oetker Group. The funding will support its IP‑licensing model for sugar producers and scale its mycoprotein production, including a vegan chicken fillet launch with Aldi. The round was highlighted in a recent Investment Climate Podcast episode.